Marea Therapeutics
PrivateLast Round
Series A
and B
Jun 18, 2024
Total Funding Raised
$190M
Company Overview
Marea (Biotechnology) is a healthcare company focused on developing innovative therapies for cardiometabolic diseases, with its lead program, MAR001, currently in Phase 2 clinical development to address remnant cholesterol and metabolic dysfunction in patients at risk for heart attacks.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marea Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Marea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A and B | Jun 18, 2024 |
Key People
Founding team and executive leadership
Marea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series A and B |
| Omega Funds | Series A and B |
| Forbion | Series A and B |
| Perceptive Xontogeny Venture Fund | Series A and B |
| Surveyor Capital | Series A and B |
| venBio | Series A and B |
| Alpha Wave Global | Series A and B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Third asset in research discovery, with DC nomination expected next year.
- Mar 4, 2026
Second asset, MAR002, enters Phase 1 for acromegaly.
Marea Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Marea Therapeutics's valuation, stock price, and market status.
